Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Transfer of Materials to Quarantine Area Post Dispensing – V 2.0

Posted on By

Elixir Department: SOP for Transfer of Materials to Quarantine Area Post Dispensing – V 2.0

Standard Operating Procedure for Transfer of Materials to Quarantine Area Post Dispensing

Department Elixir Department
SOP No. SOP/ELX/023/2025
Supersedes SOP/ELX/023/2022
Page No. Page 1 of 8
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for the safe, traceable, and compliant transfer of remaining or partially used raw materials to the quarantine area after dispensing in the Elixir Department, as per GMP requirements.

2. Scope

This SOP applies to all remaining raw material containers (API, excipients, solvents) after dispensing activity is completed for any batch in the Elixir manufacturing unit.

3. Responsibilities

  • Dispensing Operator:
    • Ensure remaining materials are properly labeled, sealed, and handed over for quarantine.
  • Warehouse Staff:
    • Transport materials back to the quarantine area with proper documentation.
  • QA Officer:
    • Verify labeling, segregation, and storage conditions in the quarantine area.
See also  Elixir Department: SOP for Use of Manufacturing Control Systems - V 2.0

4. Accountability

The Head of QA and Head of Warehouse are accountable for implementation and verification of this procedure.

5. Procedure

5.1 Preparation of Material

for Return
  1. Immediately after completion of dispensing:
    • Close the container securely using tamper-evident closures or lids.
    • Wipe the outer surface using a lint-free cloth soaked in 70% IPA.
  2. Affix “Partially Used” label with the following details:
    • Material Name
    • Batch Number
    • Remaining Quantity
    • Date of Dispensing
    • Signature of Operator

5.2 Documentation

  1. Record the return of materials in the Material Movement Register (Annexure-1).
  2. QA to cross-check with the original Material Issue Slip and Dispensing Log.
  3. Enter the following in the log:
    • Material Code
    • Returned Qty
    • Container ID
    • Returned By
    • Verified By

5.3 Transport to Quarantine Area

  1. Ensure transport trolley is clean and covered.
  2. Use dedicated pathways to avoid mix-ups with approved materials.
  3. Hand over materials to the quarantine storekeeper and obtain acknowledgment.

5.4 Storage in Quarantine Area

  1. Store returned materials in a designated quarantine rack or section.
  2. Separate materials by status – ‘To Be Re-tested,’ ‘To Be Disposed,’ or ‘For Re-approval.’
  3. Maintain controlled temperature and humidity as per material specification.

5.5 Further Actions

  1. QA to decide disposition:
    • If within expiry and uncontaminated – send for re-testing or re-approval.
    • If expired or not suitable for reuse – dispose as per SOP for waste handling.
  2. Record final decision in Material Disposition Register.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • IPA: Isopropyl Alcohol

7. Documents

  1. Material Movement Register (Annexure-1)
  2. Partial Use Label Template
  3. Material Disposition Register

8. References

  • WHO TRS 986 Annex 2 – GMP for Non-Sterile Pharmaceuticals
  • 21 CFR Part 211 – Subpart E

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Material Movement Register

Date Material Name Batch No. Returned Qty Returned By Verified By Remarks
13/04/2025 Sorbitol SB0425 2.0 kg Rajesh Kumar Sunita Reddy Sealed and labeled

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
10/01/2022 1.0 Initial Release New SOP QA Head
13/04/2025 2.0 Added material status segregation and disposition tracking Audit Requirement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Biosimilars: SOP for Endotoxin Testing in Cell Culture – V 2.0
Next Post: API Manufacturing: SOP for Sieve Integrity Verification – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version